Optimal adjuvant radiotherapy strategy for cervical cancer: a multi-center database cohort study

Fang Bai1, Guangzhe Wu1, Xinyu Qu2

  • 1Fudan University Shanghai Cancer Center, Department of Gynecologic Oncology, Shanghai, China; Fudan University, Shanghai Medical College, Department of Oncology, Shanghai, China.

Summary

Concurrent chemoradiation offers superior progression-free survival for high-risk cervical cancer patients. For intermediate-risk patients, standard radiation therapy or concurrent chemoradiation show similar outcomes, suggesting tailored treatment strategies are key.